Our goal at Siripharma Labs is to become a leader in preclinical contract research services for studies focused on customized disease models (oncology, metabolic and inflammatory disease areas).
For early stage programs, we pride ourselves in providing services in lead identification through our target establishment in-life PD models with precision and accountability. At Siripharma Labs, we transform your discoveries into successful drug products. And, Siripharma Labs provides a full range of preclinical contract research services, which include: consulting, study design, protocol preparation, data reporting and pre-IND report generation
Siripharma is led by Rajeswari RM, PhD, formerly, founder and President/CEO of Medpharmix Inc. He has his post-doctoral fellow in Temple University, UCSF and Stanford University. He has also co-authored more than 30 publications and received PhD in the area of Neuropharmacology.